A cluster of type I interferon-regulated genes associates with disease activity and prognosis in patients with IgA nephropathy.

Abstract

The exact pathogenesis of IgA nephropathy (IgAN) is complex and so far, not well defined. Since it has been shown that microbial infections could induce high levels of type I interferon (IFN-I) and there is an evident link between mucosal infection and gross hematuria in IgAN, we hypothesized that IFN-I may play a role in the pathogenic process. In this study, we investigated the type I interferon status in IgAN based on the expression of 17 IFN-regulated genes (IRGs) in whole blood from 59 IgAN patients in a cross-sectional study, of which 34 patients followed longitudinally. Analysis of the IFN-score showed that there was a significant elevated IFN-score in the IgAN patients compared with healthy controls (n = 28, p = 9.80 × 10-3), and we observed an elevated IFN-score in the group with less tubular atrophy/interstitial fibrosis (p = 1.07 × 10-2) and with a lower proportion of mesangial hypercellularity (p = 1.23 × 10-2). In the longitudinal analysis, Cox regression analysis revealed that a higher IFN level was associated with a better renal outcome in IgAN after adjustments for gender and age (hazard ratio, 0.90; 95 % confidence interval, 0.81 to 0.97; p = 4.20 × 10-2). In conclusion, our finding suggested that IFN score may represent a novel type of biomarker in IgAN, which requires further exploration on its mechanism and therapeutic targeting.

• Authors: Shu Qu, Ting Gan, Yan-Na Wang, Yuan-Yuan Qi, Yue-Miao Zhang, Celine C Berthier, Li-Jun Liu, Su-Fang Shi, Ji-Cheng Lv, Hong Zhang, Xu-Jie Zhou
• Journal: International immunopharmacology (Int Immunopharmacol) Vol. 131 Pg. 111920 (Apr 20 2024) ISSN: 1878-1705 [Electronic] Netherlands
• PMID: 38522142 (Publication Type: Journal Article)
• Copyright: Copyright © 2024 Elsevier B.V. All rights reserved.

Chemical References

• Interferon Type I

Topics

• Humans
• Glomerulonephritis, IGA (genetics, drug therapy)
• Interferon Type I (genetics, therapeutic use)
• Cross-Sectional Studies
• Prognosis
• Kidney (pathology)